Fora Capital, LLC Eli Lilly & CO Transaction History

Fora Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $6.35 Million - $8.76 Million	14,614 New	14,614 $7.85 Million
Q4 2022 Feb 08, 2023	BUY	$321.55 - $374.67 $2.17 Million - $2.53 Million	6,751 Added 77.11%	15,506 $5.67 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $2.6 Million - $2.96 Million	8,755 New	8,755 $2.83 Million
Q2 2022 Aug 11, 2022	SELL	$278.73 - $327.27 $3.13 Million - $3.67 Million	-11,229 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $2.18 Million - $2.71 Million	9,297 Added 481.21%	11,229 $3.26 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $2.62 Million - $3.25 Million	-11,636 Reduced 85.76%	1,932 $534,000
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $294,506 - $362,431	-1,329 Reduced 8.92%	13,568 $3.14 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $1.74 Million - $2.25 Million	9,613 Added 181.93%	14,897 $3.42 Billion
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $868,266 - $1.12 Million	5,284 New	5,284 $987 Million
Q3 2020 Nov 13, 2020	SELL	$146.22 - $169.13 $2.2 Million - $2.54 Million	-15,046 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $2.05 Million - $2.47 Million	15,046 New	15,046 $2.47 Billion

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.